TNF‐α has been shown to promote chemoresistance through several mechanisms, including activation of the NF‐κB pathway, regulation of drug efflux, induction of the cancer stem cell phenotype, and modulation of the TME [59]. This evidence concerns the gene NFKB1 and cancer.